Skip to main content
Top
Published in: Malaria Journal 1/2021

Open Access 01-12-2021 | Malaria | Commentary

Has COVID19 derailed Bhutan’s national malaria elimination goal? A commentary

Authors: Kinley Penjor, Tobgyal, Tandin Zangpo, Archie C. A. Clements, Darren J. Gray, Kinley Wangdi

Published in: Malaria Journal | Issue 1/2021

Login to get access

Abstract

The COVID-19 pandemic has resulted in massive global disruptions with considerable impact on the delivery of health services and national health programmes. Since the detection of the first COVID-19 case on 5th March 2020, the Royal Government of Bhutan implemented a number of containment measures including border closure and national lockdowns. Against the backdrop of this global COVID-19 pandemic response, there was a sudden surge of locally-transmitted malaria cases between June to August 2020. There were 20 indigenous cases (zero Plasmodium falciparum and 20 Plasmodium vivax) from a total of 49 cases (seven P. falciparum and 42 P. vivax) in 2020 compared to just two from a total of 42 in 2019. Over 80% of the cases were clustered in malaria endemic district of Sarpang. This spike of malaria cases was attributed to the delay in the delivery of routine malaria preventive interventions due to the COVID-19 pandemic. As a result, Bhutan is unlikely to achieve the national goal of malaria elimination by 2020.
Literature
1.
go back to reference Júnior JG, de Sales JP, Moreira MM, Pinheiro WR, Lima CKT, Neto MLR. A crisis within the crisis: the mental health situation of refugees in the world during the 2019 coronavirus (2019-nCoV) outbreak. Psychiatry Res. 2020;288:113000.PubMedPubMedCentral Júnior JG, de Sales JP, Moreira MM, Pinheiro WR, Lima CKT, Neto MLR. A crisis within the crisis: the mental health situation of refugees in the world during the 2019 coronavirus (2019-nCoV) outbreak. Psychiatry Res. 2020;288:113000.PubMedPubMedCentral
2.
go back to reference LeVine S, Dhakal GP, Penjor T, Chuki P, Namgyal K, Tshokey, et al. Case report: The First Case of COVID-19 in Bhutan. Am J Trop Med Hyg. 2020;102:1205–7. LeVine S, Dhakal GP, Penjor T, Chuki P, Namgyal K, Tshokey, et al. Case report: The First Case of COVID-19 in Bhutan. Am J Trop Med Hyg. 2020;102:1205–7.
3.
go back to reference Wangchuk S, Gyeltshen S, Dorji K, Wangdi T, Dukpa T, Namgay R, et al. Malaria elimination in Bhutan: asymptomatic malaria cases in the Bhutanese population living in malaria-risk areas and in migrant workers from India. Rev Inst Med Trop São Paulo. 2019;61:e52.PubMedPubMedCentral Wangchuk S, Gyeltshen S, Dorji K, Wangdi T, Dukpa T, Namgay R, et al. Malaria elimination in Bhutan: asymptomatic malaria cases in the Bhutanese population living in malaria-risk areas and in migrant workers from India. Rev Inst Med Trop São Paulo. 2019;61:e52.PubMedPubMedCentral
4.
go back to reference Vector-Borne Disease Control Programme. National malaria surveillance database. Ministry of Health Bhutan; 2020. Vector-Borne Disease Control Programme. National malaria surveillance database. Ministry of Health Bhutan; 2020.
5.
go back to reference VDCP. Bhutan National Malaria Strategic Plan 2015–2020. Ministry of Health Bhutan, 2015. VDCP. Bhutan National Malaria Strategic Plan 2015–2020. Ministry of Health Bhutan, 2015.
6.
go back to reference WHO. Regional Action Plan 2017–2030 towards Zero malaria-free South East Asia Region. Geneva: World Health Organization; 2017. WHO. Regional Action Plan 2017–2030 towards Zero malaria-free South East Asia Region. Geneva: World Health Organization; 2017.
7.
go back to reference Wangdi K, Xu Z, Suwannatrai AT, Kurscheid J, Lal L, Namgay R, et al. A spatio-temporal analysis to identify the drivers of malaria transmission in Bhutan. Sci Rep. 2020;10:7060.PubMedPubMedCentral Wangdi K, Xu Z, Suwannatrai AT, Kurscheid J, Lal L, Namgay R, et al. A spatio-temporal analysis to identify the drivers of malaria transmission in Bhutan. Sci Rep. 2020;10:7060.PubMedPubMedCentral
8.
go back to reference Wangdi K, Banwell C, Gatton ML, Kelly GC, Namgay R, Clements AC. Malaria burden and costs of intensified control in Bhutan, 2006–14: an observational study and situation analysis. Lancet Glob Health. 2016;4:e336-343.PubMed Wangdi K, Banwell C, Gatton ML, Kelly GC, Namgay R, Clements AC. Malaria burden and costs of intensified control in Bhutan, 2006–14: an observational study and situation analysis. Lancet Glob Health. 2016;4:e336-343.PubMed
9.
go back to reference WHO. Disease Surveillance for Malaria Elimination: an operational manual. Geneva: World Health Organization; 2012. WHO. Disease Surveillance for Malaria Elimination: an operational manual. Geneva: World Health Organization; 2012.
10.
go back to reference Vector Borne Disease Control Programme. Guidelines for Malaria surveillance and response Bhutan 2018. Minsitry of Health Bhutan; 2018. Vector Borne Disease Control Programme. Guidelines for Malaria surveillance and response Bhutan 2018. Minsitry of Health Bhutan; 2018.
11.
go back to reference Ansumana R, Sankoh O, Zumla A. Effects of disruption from COVID-19 on antimalarial strategies. Nat Med. 2020;26:1334–6.PubMed Ansumana R, Sankoh O, Zumla A. Effects of disruption from COVID-19 on antimalarial strategies. Nat Med. 2020;26:1334–6.PubMed
12.
go back to reference Ranaweera P, Wickremasinghe R, Mendis K. Preventing the re-establishment of malaria in Sri Lanka amidst the COVID-19 pandemic. Malar J. 2020;19:386.PubMedPubMedCentral Ranaweera P, Wickremasinghe R, Mendis K. Preventing the re-establishment of malaria in Sri Lanka amidst the COVID-19 pandemic. Malar J. 2020;19:386.PubMedPubMedCentral
Metadata
Title
Has COVID19 derailed Bhutan’s national malaria elimination goal? A commentary
Authors
Kinley Penjor
Tobgyal
Tandin Zangpo
Archie C. A. Clements
Darren J. Gray
Kinley Wangdi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2021
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03562-5

Other articles of this Issue 1/2021

Malaria Journal 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.